胎盤特異性蛋白9(PLAC9)多克隆抗體 

• 來(lái)源多抗制備
• 宿主兔
• 效價(jià)-
• Ig類型IgG
• 純化方式抗原特異性親和純化
• 胎盤特異性蛋白9(PLAC9)多克隆抗體標(biāo)記物無(wú)標(biāo)記物
• **原-
• 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
• 性狀液體
• 濃度200ug/ml
• 且適物種-
• 應(yīng)用WB, ICC, IHC-P, IHC-F, ELISA
• 胎盤特異性蛋白9(PLAC9)多克隆抗體Polyclonal Antibody Antibody Antibody Antibody to Placenta Placenta Placenta Placenta Specific Specific Specific Specific Protein Protein Protein Protein 9 (PLAC9) (PLAC9) (PLAC9) (PLAC9)
  Organism: Organism: Organism: Organism: Homo sapiens sapiens sapiens sapiens (Human) (Human) (Human) (Human)
  Instruction Instruction Instruction Instruction manual
  FOR IN VITRO USE AND RESEARCH USE ONLY
  NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
  7th Edition (Revised in May, 2013)
  [ PRODUCT PRODUCT PRODUCT PRODUCT INFORMATION INFORMATION INFORMATION INFORMATION ]
  Immunogen: Immunogen: Immunogen: Immunogen: PLAC9, Human
  Clonality: Clonality: Clonality: Clonality: Polyclonal
  Host: Rabbit
  Immunoglobulin Immunoglobulin Immunoglobulin Immunoglobulin Type: IgG
  Purification: Purification: Purification: Purification: Affinity Chromatography.
  Applications Applications Applications Applications: WB, ICC, IHC-P, IHC-F, ELISA
  Concentration: Concentration: Concentration: Concentration: 200μg/mL
  UOM: 100μg
  胎盤特異性蛋白9(PLAC9)多克隆抗體[ IMMUNOGEN IMMUNOGEN IMMUNOGEN IMMUNOGEN INFORMATION INFORMATION INFORMATION INFORMATION ]
  Immunogen: Immunogen: Immunogen: Immunogen: Recombinant PLAC9 (Ala23~Phe97) expressed in E.coli. USCN Accession Accession Accession Accession No.: rP84741Hu01
  Sequence: Sequence: Sequence: Sequence: The target protein is fused with two N-terminal Tags, His-tag and
  T7-tag and its sequence is listed below.
  MGSSHHHHHH SSGLVPRGSH MASMTGGQQM GRGSEF- AEPFSPPR GDSAQSTACD
  RHMAVQRRLD VMEEMVEKTV DHLGTEVKGL LGLLEELAWN LPPGPFSPAP DLLGDGF
  [ ANTIBODY ANTIBODY ANTIBODY ANTIBODY SPECIFITY ]
  The antibody is a rabbit polyclonal antibody raised against PLAC9. It has been
  selected for its ability to recognize PLAC9 in immunohistochemical staining and
  western blotting.
  [ APPLICATIONS APPLICATIONS APPLICATIONS APPLICATIONS ]
  Western blotting: 1:100-400
  Immunocytochemistry in formalin fixed cells: 1:100-500
  Immunohistochemistry in formalin fixed frozen section: 1:100-500
  Immunohistochemistry in paraffin section: 1:50-200
  Enzyme-linked Immunosorbent Assay: 1:100-200
  Optimal working dilutions must be determined by end user.
  [ IMAGES ]
  胎盤特異性蛋白9(PLAC9)多克隆抗體[ CONTENTS CONTENTS CONTENTS CONTENTS ]
  Form & Buffer: Supplied as solution form in PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
  [ QUALITY QUALITY QUALITY QUALITY CONTROL ]
  Content: Content: Content: Content: The quality control contains recombinant PLAC9 (Ala23~Phe97)
  disposed in loading buffer.
  Usage: 10uL per well when 3,3'-Diaminobenzidine(DAB) as the substrate.
  5uL pe r well when used in enhan ced chemil umes cent (ECL ).
  Note: The quality control is specifically manufactured as the positive control.
  Not used for other purposes.
  Loading Loading Loading Loading Buffer: 100mM Tris(pH8.8), 2% SDS, 200mM NaCl, 50% glycerol, BPB 0.01%, NaN3 0.02%.
  [ STORAGE ]
  Store at 4oC for frequent use. Stored at -20oC to -80oC in a manual defrost freezer
  for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
  Used in DAB staining staining staining staining on fromalin fromalin fromalin fromalin fixed
  paraffin- paraffin- paraffin- paraffin- embedded embedded embedded embedded Heart tissue
  Used in Western Western Western Western Blot ,Sample: ,Sample: ,Sample: ,Sample:
  Recombinant Recombinant Recombinant Recombinant PLAC9,Human PLAC9,Human PLAC9,Human PLAC9,Human